Clinical Trials Logo
  1. Home
  2. Cancer of the Lung
  3. NCT04889989

Microwave Ablation in Chinese Patients With Lung Tumors

Cancer of the Lung Clinical Trial

Official title:
A Single-Arm, Prospective, Multicenter Study to Evaluate the Effectiveness and Safety of the NeuWave Certus Microwave Ablation System in Chinese Patients With Primary or Secondary Tumors in the Lung

Clinical Trial Summary

Adult patients with non-small cell lung cancer (NSCLC) or oligometastatic lung tumors will all receive microwave ablation (MWA) performed percutaneously by doctors who are experienced in lung tumor ablation. 120 patients will participate across 8 clinical study sites all in China.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04889989
Study type Interventional
Source Ethicon, Inc.
Contact
Status Terminated
Phase N/A
Start date December 27, 2021
Completion date September 14, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT01860898 - A Phase I Study of iPS Cell Generation From Patients With COPD N/A
Active, not recruiting NCT01785537 - The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study N/A
Completed NCT00716157 - Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation N/A
Completed NCT00780611 - Investigating the Improvement in 4D CT Images Using AV Biofeedback
Terminated NCT02673021 - MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) N/A
Terminated NCT03603652 - NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung N/A
Terminated NCT02715102 - Circulating Tumor DNA in Patients at High Risk for Lung Cancer N/A
Not yet recruiting NCT05857995 - Precision Lung Cancer Survivorship Care Intervention N/A
Withdrawn NCT03713099 - NEUWAVE Flexible Probe Study #2 N/A
Completed NCT01109524 - Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer Phase 2
Recruiting NCT04699188 - Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation Phase 1/Phase 2
Completed NCT02410603 - Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
Completed NCT00328588 - LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy Phase 2
Recruiting NCT02549638 - Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
Completed NCT02370303 - A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System